BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22767378)

  • 1. Determination of hepatic clearance with the account of drug-protein binding kinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Oct; 101(10):3936-45. PubMed ID: 22767378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.
    Jansen JA
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):15-26. PubMed ID: 7229915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic elimination of drugs with concentration-dependent serum protein binding.
    Huang JD; Oie S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the prediction of hepatic clearance using the diluted plasma in metabolic stability assay.
    Berezhkovskiy LM; Khojasteh SC; Halladay JS; Hop CE
    J Pharm Sci; 2009 Jun; 98(6):1922-7. PubMed ID: 18837013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
    Ye M; Nagar S; Korzekwa K
    Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.
    Yan Z; Ma L; Carione P; Huang J; Hwang N; Kenny JR; Hop CECA
    J Pharm Sci; 2024 Apr; 113(4):1094-1112. PubMed ID: 38220087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.
    Baker M; Parton T
    Xenobiotica; 2007; 37(10-11):1110-34. PubMed ID: 17968739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Feb; 98(2):748-62. PubMed ID: 18506769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of liver disease on drug pharmacokinetics].
    Su CY
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
    [No Abstract]   [Full Text] [Related]  

  • 16. Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.
    Meijer DK; van der Sluijs P
    Pharm Res; 1989 Feb; 6(2):105-18. PubMed ID: 2668913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
    Wang HJ; Benet LZ
    Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.